Relay Therapeutics (RLAY) Operating Margin (2020 - 2025)
Historic Operating Margin for Relay Therapeutics (RLAY) over the last 6 years, with Q2 2025 value amounting to 11351.11%.
- Relay Therapeutics' Operating Margin changed N/A to 11351.11% in Q2 2025 from the same period last year, while for Sep 2025 it was 3914.38%, marking a year-over-year decrease of 1198100.0%. This contributed to the annual value of 3722.07% for FY2024, which is 22619600.0% down from last year.
- Latest data reveals that Relay Therapeutics reported Operating Margin of 11351.11% as of Q2 2025.
- In the past 5 years, Relay Therapeutics' Operating Margin ranged from a high of 9219600.0% in Q4 2023 and a low of 89117.65% during Q2 2023
- In the last 5 years, Relay Therapeutics' Operating Margin had a median value of 11944.09% in 2021 and averaged 595567.98%.
- Its Operating Margin has fluctuated over the past 5 years, first crashed by 2000000000bps in 2021, then soared by 2000000000bps in 2023.
- Over the past 5 years, Relay Therapeutics' Operating Margin (Quarter) stood at 11944.09% in 2021, then crashed by -141bps to 28794.86% in 2022, then surged by 32118bps to 9219600.0% in 2023, then plummeted by -100bps to 903.0% in 2024, then tumbled by -1157bps to 11351.11% in 2025.
- Its Operating Margin stands at 11351.11% for Q2 2025, versus 1105.21% for Q1 2025 and 903.0% for Q1 2024.